NANOVIRICIDES, INC. Intangible Assets, Net (Excluding Goodwill)
NANOVIRICIDES, INC. (NNVC) had Intangible Assets, Net (Excluding Goodwill) of $310.84 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-05-15
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $310.84K.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $312.90K.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $314.97K.
- 2025-06-30: Intangible Assets, Net (Excluding Goodwill) $317.04K.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2026-03-31 | $310.84K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $312.90K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $314.97K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $317.04K 10-Q · filed 2026-05-15 |
| 2025-03-31 | $319.11K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $321.17K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $323.24K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $325.31K 10-K · filed 2025-09-29 |
| 2024-03-31 | $327.38K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $329.44K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $331.51K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $333.58K 10-K · filed 2024-09-27 |
| 2023-03-31 | $335.65K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $337.71K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $339.78K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $341.85K 10-K · filed 2023-10-13 |
| 2022-03-31 | $343.92K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $345.98K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $348.05K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $350.12K 10-K · filed 2022-10-13 |
| 2021-03-31 | $352.19K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $354.25K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $356.32K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $358.39K 10-K · filed 2021-10-12 |
| 2020-03-31 | $360.45K 10-Q · filed 2020-06-22 |
| 2019-12-31 | $362.52K 10-Q · filed 2020-02-14 |
| 2019-09-30 | $364.59K 10-Q · filed 2019-11-15 |
| 2019-06-30 | $366.66K 10-K · filed 2020-10-13 |
| 2019-03-31 | $368.73K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $370.79K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $372.86K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $374.93K 10-K · filed 2019-08-23 |
| 2018-03-31 | $377.00K 10-Q · filed 2018-05-21 |
| 2017-12-31 | $379.06K 10-Q · filed 2018-02-20 |
| 2017-09-30 | $381.13K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $383.20K 10-K · filed 2018-10-12 |
| 2017-03-31 | $385.27K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $387.33K 10-Q · filed 2017-02-14 |
| 2016-09-30 | $389.40K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $391.47K 10-K · filed 2017-09-28 |
| 2016-03-31 | $393.54K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $395.60K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $397.67K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $399.74K 10-K · filed 2016-09-16 |
| 2015-03-31 | $401.81K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $403.87K 10-Q · filed 2015-02-25 |
| 2014-09-30 | $406.06K 10-Q/A · filed 2015-02-23 |
| 2014-06-30 | $408.26K 10-K · filed 2015-09-14 |
| 2014-03-31 | $410.45K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $412.65K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $414.84K 10-Q/A · filed 2015-02-23 |
| 2013-06-30 | $417.03K 10-K · filed 2015-02-23 |
| 2013-03-31 | $419.23K 10-Q/A · filed 2013-05-20 |
| 2012-12-31 | $421.42K 10-Q/A · filed 2013-02-22 |
| 2012-09-30 | $423.61K 10-Q · filed 2012-11-19 |
| 2012-06-30 | $425.81K 10-K/A · filed 2013-10-08 |
| 2012-03-31 | $428.00K 10-Q · filed 2012-05-21 |
| 2011-12-31 | $418.99K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $402.92K 10-Q/A · filed 2011-12-12 |
| 2011-06-30 | $399.38K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |